Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2, indicating a minor release. The 'Back to Top' navigation link was removed, a minor UI change with no impact on core content.
    Difference
    0.1%
    Check dated 2025-09-12T23:39:02.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-05T19:33:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding Milan and Padua in Italy, while removing previous location terms and related topics. Additionally, the revision number has been updated to v3.0.0.
    Difference
    2%
    Check dated 2025-08-29T15:40:56.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-15T10:29:20.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-08-08T08:38:46.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.6%
    Check dated 2025-08-01T05:08:28.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.